(co-encapsulation,1)
(dynamic,1)
(value-based,2)
(neuroma,3)
(it,3)
(neoadjuvant,2)
(previous,3)
(pathological,1)
(delay,1)
(such,4)
(formed,1)
(discussed,1)
(intervention,1)
(missed,1)
(levonorgestrel,1)
(a-carotene,1)
(evidence,1)
(chemotherapy,1)
(corresponding,1)
(suspicion,1)
(7/18,1)
(applications,1)
(CONCLUSION,2)
(Diagnostic,1)
(25,5)
(To,1)
(Future,1)
(19450,1)
(1062,1)
(required,1)
(substantially,1)
(these,4)
(research,1)
(paradigm,1)
(inconsistent,1)
(release,1)
(conducted,2)
(Thirteen,1)
(techniques,1)
(not,10)
(process,1)
(enable,1)
(carcinoma,2)
(most,4)
(practice,1)
(detectability,1)
(provided,1)
(68Ga-Pentixafor,5)
(be,8)
(modalities,1)
(axilla,1)
(2016,1)
(generated,1)
(16.4,1)
(larger,1)
(EVIDENCE,1)
(scrutiny,1)
(AND,1)
(ml,2)
(tomosynthesis,1)
(0.02;,1)
(functional,1)
(PEGylated,1)
(increasing,2)
(tumor,4)
(ratio,1)
(follow-up,1)
(malignancy,2)
(Based,1)
(small,4)
(concerns,1)
(necessary,2)
(36,1)
(had,4)
(on,11)
(suitable,1)
(signatures,5)
(Management,1)
(summarized,1)
(before,5)
(pooled,1)
(at,9)
(4.0%,1)
(diffusion-weighted,1)
(random,1)
(175,1)
(and/or,1)
(T/B,1)
(factor,3)
(outpatient,1)
(overexpressed,1)
(gadolinium-based,1)
(RESON,1)
(sampling,1)
(reviewed,1)
(relatives,2)
(cases,12)
(drains,1)
(use,5)
(multi-omics,1)
(image,1)
(pituitary,2)
(0.001,1)
(reduction,1)
(or,9)
(compared,5)
(0.049,1)
(wound,1)
(effective,2)
(properties,1)
(of,106)
(diagnostic,5)
(tools,1)
(months,4)
(management,2)
(lutein,1)
(possibility,1)
(desquamation,1)
(investigate,1)
(assessed,1)
(potentially,1)
(therapies,1)
(inhibitory,1)
(seroma,7)
(variation,2)
(retinol,1)
(These,3)
(Forty-three,1)
(studies,8)
(existing,1)
(definitive,1)
(MAGN,1)
(maintaining,1)
(People,1)
(makers,1)
(clinical,4)
(PET,10)
(Efforts,1)
(metastatic,3)
(selected,1)
(immune,2)
(grade,2)
(side,1)
(colon,2)
(remains,2)
(injection,1)
(regional,1)
(should,1)
(frequently,1)
(significant,3)
(P=0.2,1)
(did,4)
(38.7%,1)
(Centre,1)
(cancer-specific,1)
(prediction,2)
(estradiol,1)
(present,3)
(latest,1)
(susceptibility,1)
(reported,8)
(also,1)
(NST,1)
(locally-advanced,2)
(limit,1)
(NIRF,2)
(cancers,4)
(exam,1)
(72,1)
(entity,1)
(feasible,2)
(by,4)
(far,1)
(presence,1)
(recent,3)
(presenting,1)
(criteria,1)
(quality,1)
(confirmed,1)
(risk,11)
(beam,1)
(14,1)
(increment,1)
(46.6%,1)
(60%,1)
(growth,1)
(whole,1)
(43.6,1)
(PubMed,1)
(might,1)
(higher,7)
(semi-quantitatively,1)
(external,1)
(chemokine,1)
(3,1)
(dense,1)
(consistently,1)
(based,1)
(18F-FDG,3)
(prolactinoma,4)
(refractory,1)
(stratified,1)
(OF,1)
(within,1)
(Hence,1)
(involved,1)
(appealing,1)
(25.6,1)
(that,12)
(protocols,4)
(underlines,1)
(many,1)
(lobular,1)
(Multivariate,1)
(sensitivity,1)
(AION,6)
(strong,4)
(15.9,1)
(to,31)
(large,1)
(system-both,1)
(applicable,1)
(broader,1)
(20%,1)
(differential,1)
(age,5)
(Seroma,1)
(ultrasound,1)
(unenhanced,1)
(and,82)
(being,2)
(familial,1)
(0.70,1)
(postmenopausal,1)
